In the following years, it is believed that the cell of origin in CML is characterized through specific genomic alteration of the CD34+CD38− subset of HSCs leading to Ph chromosome and the expression of fusion tyrosine kinase BCR-ABL1 and leukemogenesis [9]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.